Sebacic Acid-Crosslinked PGS Dressing for Sustained Drug Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing absorbent dressings based on poly(glycerol sebacate) (PGS) face issues such as rapid degradation, leaching of polymer components, lack of mechanical strength, and inability to absorb wound secretions, making them unsuitable for open wounds and hindering wound observation.
Innovation Solution
A PGS-based absorbent material is developed with a crosslinking process using sebacic acid to achieve an equimolar ratio of functional groups, incorporating an active substance like adenosine, and a curing process at controlled temperatures to ensure mechanical strength and sustained release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If electrospinning is used to produce fibrous dressings from PGS, then the dressings can deliver active substances, but the dressings degrade very quickly with 20% weight loss within 24 hours and 45% weight loss after 21 days
Solution Approach 1:
The patent changes the physical and chemical parameters of PGS by crosslinking it with sebacic acid, transforming the linear polymer chains into a three-dimensional network structure. This parameter change increases molecular weight and reduces chain mobility, thereby significantly improving dressing durability while maintaining drug delivery capability through the crosslinked network structure
Solution Approach 2:
The patent creates a composite material system by combining PGS with sebacic acid crosslinking agents. This composite approach forms a crosslinked PGS network that integrates the biocompatibility and biodegradability of PGS with the enhanced mechanical strength and stability provided by the crosslinked structure, resolving the contradiction between softness and durability
2Ease of manufacture
If PGS dressings are made without crosslinking, then the manufacturing process is simple, but PGS oligomers leach into the wound environment and cause inflammatory reactions
Solution Approach 1:
The patent applies a chemical modification parameter change by introducing crosslinking reactions between PGS and sebacic acid. This changes the molecular architecture from linear to crosslinked network, preventing oligomer leaching while maintaining manufacturing feasibility through a single-step crosslinking process that can be performed under controlled conditions
Solution Approach 2:
The patent uses sebacic acid as an intermediary crosslinking agent that mediates between PGS chains. This intermediary substance forms covalent bonds between polymer chains, creating a stable network that prevents oligomer release, while the intermediary itself is biocompatible and does not cause harmful effects
3Strength
If crosslinking is performed by light exposure, then the dressing structure is hardened, but a specialist is required to irradiate the dressing with appropriate radiation dose
Solution Approach 1:
The patent replaces the optical/photonic system (light irradiation) with a thermal system (heat treatment). Instead of using light to initiate crosslinking, the patent employs thermal energy to activate the crosslinking reaction between PGS and sebacic acid, making the process accessible to patients without requiring specialized equipment or professional intervention
Solution Approach 2:
The patent enables self-service application by designing a crosslinking process that patients can perform themselves using simple heat sources. The thermal crosslinking method allows patients to harden their own dressings at home without requiring a specialist to administer light irradiation, empowering patients to manage their own wound care
4Volume of moving object
If non-woven fabrics are used for dressings, then the dressings are thin, but they obscure the wound and prevent observation of the healing process
Solution Approach 1:
The patent creates a composite material with unique optical properties by combining crosslinked PGS with specific additives or structural features. This composite structure maintains thinness for comfort while introducing transparency or optical clarity that allows wound observation, resolving the contradiction between thinness and visibility
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The resulting absorbent material provides mechanical stability, sustained release of active substances, and transparency for wound observation, suitable for open wounds with improved reproducibility and patient self-application.
Implementation Method 1
the absorbent material comprises a poly(glycerol sebacate) prepolymer crosslinked with sebacic acid
Implementation Method 2
the formed absorbent material is cured at an elevated temperature
Implementation Method 3
ensures a linear release of the active substance by diffusion
Data Source
AI summary
An object of the invention is an absorbent material, in particular a dressing material, build of poly(glycerol sebacate), called absorbent material made of PGS, containing an active substance, and a method of absorbent material made of PGS containing an active substance fabrication. In the absorbent material, the active substance may be adenosine. The active substance is placed during the moulding process and therefore no subsequent modification/treatment of the absorbent material is necessary. The composition of the polymer mixture reduces shrinkage during curing, shortens the curing process and ensures linear release of the active substance by diffusion. The method of the absorbent material made of PGS fabrication according to the invention provides a cured absorbent material, which is preferably placed in a polyamide/polyethylene bag and then sterilised.